Thursday, Sep 28, 2023
chiefmarketingofficer.blog
chiefmarketingofficer.blog
CLOSE
Chief Marketing Officer

Innovent Updates Phase 1b Data of IBI939 (Anti-TIGIT Monoclonal Antibody) Combined with Sintilimab in Previously Untreated PD-L1-selected NSCLC at the 2023 ASCO Annual Meeting

By Jeffrey Pena June 4, 2023 0 mins read 94 Views


Share This
Latest Posts
@CEOConsultants: https://t.co/DnSWBLP957
@CEOConsultants: https://t.co/DnSWBLP957
September 23, 2023 14 Views
@CEOConsultants: https://t.co/aK2bBPNj91
@CEOConsultants: https://t.co/aK2bBPNj91
September 23, 2023 17 Views
@CEOConsultants: https://t.co/qdWK6lA2oT
@CEOConsultants: https://t.co/qdWK6lA2oT
September 23, 2023 10 Views
@CEOConsultants: https://t.co/h26DtHAgcp
@CEOConsultants: https://t.co/h26DtHAgcp
September 22, 2023 12 Views
@CEOConsultants: https://t.co/0jvSkC2YFV
@CEOConsultants: https://t.co/0jvSkC2YFV
September 22, 2023 11 Views
@CEOConsultants: https://t.co/K2RPo1SO6V
@CEOConsultants: https://t.co/K2RPo1SO6V
September 22, 2023 11 Views
Categories
Trending Posts